Can-Fite BioPharma Ltd. Quarterly Contract with Customer, Liability, Noncurrent in USD from Q4 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary
Can-Fite BioPharma Ltd. quarterly Contract with Customer, Liability, Noncurrent history and growth rate from Q4 2022 to Q4 2023.
  • Can-Fite BioPharma Ltd. Contract with Customer, Liability, Noncurrent for the quarter ending December 31, 2023 was $1.71M, a 25.4% decline year-over-year.
Contract with Customer, Liability, Noncurrent, Quarterly (USD)
Contract with Customer, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.71M -$582K -25.4% Dec 31, 2023 20-F 2024-03-28
Q4 2022 $2.3M Dec 31, 2022 20-F 2024-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.